SAH hydrolase inhibitors (Future Medicine)

N/A

Report date: 2025/01/26 17:57:31
NME

Base Information

Drug NameSAH hydrolase inhibitors (Future Medicine)
Drug Alias Name6',6'-difluoroaristeromycin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosylhomocysteinase inhibitors
TargetsAdenosylhomocysteinase
Therapy Area/IndicationsRNA Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFuture Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFuture Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsRNA Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A